
Sign up to save your podcasts
Or


This episode of Let's Talk About Kidneys, Dr. Saim, a nephrologist with Dallas Nephrology Associates, discusses what is new in kidney transplant. The podcast discusses advancements in kidney transplantation, focusing on the benefits and risks of living and deceased donor transplant. Dr. Saim highlights that over 25,000 transplants were performed last year, with nearly 7,000 from living donors. Living donor transplants offer better survival rates and shorter waiting time. The waiting list has nearly 100,000 patients, with blood group O having the longest wait. Deceased donor transplants used KDPI to assess donor quality. High KDPI kidneys benefit diabetics over 50. The conversation also covers post-transplant care, recovery, and the use of new immunosuppressive belatacept drugs. Future prospects include artificial kidneys and xenotransplants.
By Dallas Nephrology Associates5
77 ratings
This episode of Let's Talk About Kidneys, Dr. Saim, a nephrologist with Dallas Nephrology Associates, discusses what is new in kidney transplant. The podcast discusses advancements in kidney transplantation, focusing on the benefits and risks of living and deceased donor transplant. Dr. Saim highlights that over 25,000 transplants were performed last year, with nearly 7,000 from living donors. Living donor transplants offer better survival rates and shorter waiting time. The waiting list has nearly 100,000 patients, with blood group O having the longest wait. Deceased donor transplants used KDPI to assess donor quality. High KDPI kidneys benefit diabetics over 50. The conversation also covers post-transplant care, recovery, and the use of new immunosuppressive belatacept drugs. Future prospects include artificial kidneys and xenotransplants.

27,239 Listeners

1,625 Listeners

32 Listeners

29,285 Listeners

36 Listeners

0 Listeners

10 Listeners